Teva Pharma Industries Stock Price History
| TEVA Stock | USD 15.62 0.11 0.71% |
Below is the normalized historical share price chart for Teva Pharma Industries extending back to November 07, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Teva Pharma stands at 15.62, as last reported on the 2nd of May, with the highest price reaching 15.88 and the lowest price hitting 15.45 during the day.
If you're considering investing in Teva Stock, it is important to understand the factors that can impact its price. Teva Pharma Industries owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0453, which indicates the firm had a -0.0453 % return per unit of risk over the last 3 months. Teva Pharma Industries exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Teva Pharma's Risk Adjusted Performance of (0.21), coefficient of variation of (760.24), and Variance of 10.73 to confirm the risk estimate we provide. At present, Teva Pharma's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 24.9 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 789 M. . At present, Teva Pharma's Price To Operating Cash Flows Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Cash Flow Ratio is expected to grow to 26.00, whereas Price To Sales Ratio is forecasted to decline to 1.45. Teva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of March 1990 | 200 Day MA 17.5268 | 50 Day MA 15.326 | Beta 0.718 |
Sharpe Ratio = -0.0453
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TEVA |
Estimated Market Risk
| 2.85 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Teva Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teva Pharma by adding Teva Pharma to a well-diversified portfolio.
Price Book 3.2063 | Enterprise Value Ebitda 41.6406 | Price Sales 1.0413 | Shares Float 1.1 B | Wall Street Target Price 22.3838 |
Teva Pharma Stock Price History Chart
There are several ways to analyze Teva Stock price data. The simplest method is using a basic Teva candlestick price chart, which shows Teva Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 6, 2025 | 17.29 |
| Lowest Price | April 10, 2025 | 12.82 |
Teva Pharma May 2, 2025 Stock Price Synopsis
Various analyses of Teva Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Teva Stock. It can be used to describe the percentage change in the price of Teva Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Teva Stock.| Teva Pharma Price Rate Of Daily Change | 1.01 | |
| Teva Pharma Price Action Indicator | 0.01 | |
| Teva Pharma Price Daily Balance Of Power | 0.26 | |
| Teva Pharma Accumulation Distribution | 250,584 |
Teva Pharma May 2, 2025 Stock Price Analysis
Teva Stock Price History Data
The price series of Teva Pharma for the period between Sat, Feb 1, 2025 and Fri, May 2, 2025 has a statistical range of 8.71 with a coefficient of variation of 9.27. The price distribution for the period has arithmetic mean of 15.8. The median price for the last 90 days is 16.1. The company completed stock split (2:1) on 1st of July 2004. Teva Pharma Industries had dividends distributed to its stock-holders on 2017-11-27.| Open | High | Low | Close | Volume | ||
| 05/01/2025 | 15.56 | 15.88 | 15.45 | 15.62 | 9,254,137 | |
04/30/2025 | 15.53 | 15.62 | 15.31 | 15.51 | 8,892,605 | |
04/29/2025 | 15.15 | 15.72 | 15.04 | 15.58 | 13,753,370 | |
04/28/2025 | 15.33 | 15.45 | 14.81 | 15.02 | 12,005,800 | |
| 04/25/2025 | 14.65 | 14.90 | 14.52 | 14.87 | 6,566,598 | |
| 04/24/2025 | 14.34 | 14.77 | 14.17 | 14.72 | 8,360,200 | |
04/23/2025 | 14.33 | 14.61 | 14.21 | 14.29 | 10,702,315 | |
04/22/2025 | 13.80 | 14.07 | 13.61 | 14.00 | 12,002,319 | |
| 04/21/2025 | 13.46 | 13.46 | 13.04 | 13.31 | 12,058,651 | |
| 04/17/2025 | 13.54 | 13.74 | 13.44 | 13.65 | 8,836,359 | |
| 04/16/2025 | 13.62 | 13.64 | 13.24 | 13.43 | 7,209,510 | |
| 04/15/2025 | 13.40 | 13.80 | 13.40 | 13.60 | 7,216,452 | |
04/14/2025 | 13.69 | 13.83 | 13.27 | 13.60 | 10,292,316 | |
04/11/2025 | 13.00 | 13.46 | 12.88 | 13.46 | 12,223,016 | |
04/10/2025 | 13.90 | 13.95 | 12.47 | 12.82 | 20,531,142 | |
04/09/2025 | 13.36 | 14.33 | 12.70 | 14.16 | 28,632,687 | |
| 04/08/2025 | 14.41 | 14.41 | 13.27 | 13.59 | 12,352,060 | |
04/07/2025 | 14.36 | 14.55 | 13.35 | 13.94 | 17,802,311 | |
04/04/2025 | 14.52 | 14.53 | 13.30 | 13.80 | 18,088,636 | |
04/03/2025 | 14.97 | 15.54 | 14.76 | 14.85 | 8,174,355 | |
04/02/2025 | 15.13 | 15.35 | 15.09 | 15.29 | 7,745,604 | |
| 04/01/2025 | 15.35 | 15.47 | 15.08 | 15.29 | 8,287,202 | |
03/31/2025 | 14.81 | 15.53 | 14.70 | 15.37 | 18,504,010 | |
03/28/2025 | 15.49 | 15.50 | 14.87 | 15.08 | 7,844,693 | |
03/27/2025 | 15.68 | 15.80 | 15.45 | 15.49 | 6,238,664 | |
03/26/2025 | 15.50 | 15.75 | 15.28 | 15.69 | 11,354,606 | |
03/25/2025 | 16.26 | 16.26 | 15.64 | 15.70 | 11,471,434 | |
03/24/2025 | 15.94 | 16.28 | 15.94 | 16.18 | 8,024,012 | |
| 03/21/2025 | 16.00 | 16.20 | 15.90 | 16.10 | 9,419,443 | |
03/20/2025 | 16.18 | 16.55 | 16.16 | 16.24 | 7,839,717 | |
03/19/2025 | 16.45 | 16.57 | 16.06 | 16.29 | 9,377,919 | |
03/18/2025 | 16.69 | 16.70 | 16.23 | 16.48 | 9,443,101 | |
03/17/2025 | 16.25 | 16.89 | 16.23 | 16.71 | 9,676,434 | |
| 03/14/2025 | 16.45 | 16.51 | 16.17 | 16.33 | 6,488,971 | |
03/13/2025 | 16.39 | 16.92 | 16.22 | 16.46 | 14,889,169 | |
03/12/2025 | 16.22 | 16.70 | 16.05 | 16.48 | 16,469,472 | |
03/11/2025 | 14.70 | 16.22 | 14.67 | 16.10 | 20,889,040 | |
03/10/2025 | 15.08 | 15.09 | 14.45 | 14.67 | 13,338,908 | |
03/07/2025 | 15.38 | 15.46 | 15.02 | 15.36 | 11,322,886 | |
03/06/2025 | 15.58 | 15.74 | 15.17 | 15.35 | 16,377,309 | |
03/05/2025 | 15.69 | 16.13 | 15.68 | 15.90 | 14,366,726 | |
03/04/2025 | 15.75 | 16.06 | 15.27 | 15.69 | 14,737,130 | |
03/03/2025 | 16.44 | 16.53 | 15.86 | 16.00 | 9,872,681 | |
02/28/2025 | 16.22 | 16.46 | 16.06 | 16.46 | 9,515,574 | |
02/27/2025 | 16.65 | 16.89 | 16.28 | 16.32 | 10,723,934 | |
02/26/2025 | 16.82 | 17.13 | 16.61 | 16.78 | 7,478,126 | |
02/25/2025 | 16.82 | 16.86 | 16.27 | 16.61 | 13,131,518 | |
02/24/2025 | 16.66 | 16.92 | 16.32 | 16.78 | 11,847,715 | |
02/21/2025 | 17.02 | 17.07 | 16.61 | 16.74 | 9,634,065 | |
02/20/2025 | 17.51 | 17.63 | 17.00 | 17.00 | 10,127,584 | |
02/19/2025 | 16.68 | 17.52 | 16.61 | 17.16 | 16,972,406 | |
02/18/2025 | 17.15 | 17.15 | 16.35 | 16.57 | 19,458,991 | |
| 02/14/2025 | 16.58 | 16.63 | 16.08 | 16.25 | 12,474,918 | |
02/13/2025 | 16.50 | 16.74 | 16.35 | 16.63 | 11,072,156 | |
02/12/2025 | 16.43 | 16.49 | 16.13 | 16.34 | 12,964,004 | |
02/11/2025 | 16.68 | 16.84 | 16.45 | 16.59 | 10,166,628 | |
02/10/2025 | 17.02 | 17.12 | 16.62 | 16.81 | 9,208,562 | |
02/07/2025 | 17.27 | 17.31 | 16.61 | 16.83 | 14,407,207 | |
02/06/2025 | 17.27 | 17.58 | 17.23 | 17.29 | 9,325,984 | |
02/05/2025 | 17.35 | 17.52 | 17.20 | 17.21 | 12,436,849 | |
02/04/2025 | 17.35 | 17.58 | 17.00 | 17.06 | 16,764,369 |
About Teva Pharma Stock history
Teva Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Teva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Teva Pharma Industries will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Teva Pharma stock prices may prove useful in developing a viable investing in Teva Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.1 B | 789 M | |
| Net Loss | -2.1 B | -2 B |
Teva Pharma Stock Technical Analysis
Teva Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Teva Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Teva Pharma's price direction in advance. Along with the technical and fundamental analysis of Teva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Teva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.21) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.16) | |||
| Treynor Ratio | (0.44) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |